CAPR R&D to Revenue
Capricor Therapeutics Inc · R&D to Revenue
CAPR R&D to Revenue
Latest reported0.00%period ending
CAPR FY R&D/Revenue (0.00% → 0.00%)
Latest values, visible window
High-resolution chart · PNG
CAPR r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 0% | |
| 224.3715% | |
| 144.7611% | |
| 855.074% | |
| 5,541.5091% | |
| 2,725.8662% | |
| 511.6081% | |
| 722.1424% | |
| 403.826% | |
| 502.884% | |
| 364.3273% | |
| 186.8731% | |
| 1,032.7224% | |
| 523.7852% | |
| 305.3137% | |
| 0% | |
| 0% | |
| 0% | |
| 5,053.2544% | |
| 708.9832% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |